<DOC>
	<DOCNO>NCT00222170</DOCNO>
	<brief_summary>The purpose study determine production mucin GERD/RE subject 8 week treatment rabeprazole .</brief_summary>
	<brief_title>Rabeprazole Subjects With Gastroesophageal Reflux Disease ( GERD )</brief_title>
	<detailed_description>Enrolled patient undergo collection salivary esophageal secretion . Subsequently , patient receive rabeprazole ( 20mg QD ) 8 week re-endoscoped confirm complete heal reflux esophagitis . In patient completely heal reflux esophagitis second collection salivary esophageal secretion implement . In secretion , adequately cod laboratory Research Fellow ( blind term sample collect treatment rabeprazole ) content mucin measure use commercially available assay secretion express unit per minute collection time .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criterion : 24 patient endoscopically confirm reflux esophagitis ( Grades AD accord LA classification ) patient chronic symptom GERD ( heartburn without regurgitation ) age 19 79 , 12M &amp; 12F , include . Exclusion criterion : History GI surgery , primary esophageal motor disorder , systemic disease , history drug alcohol abuse , pregnancy nursing , allergy drug class rabeprazole , need concurrent therapy affect salivary secretion ( cause socalled `` dry mouth syndrome '' ) .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2007</verification_date>
</DOC>